RVNC Annual Total Assets
$478.45 M
-$103.45 M-17.78%
31 December 2023
Summary:
As of January 20, 2025, RVNC annual total assets is $478.45 million, with the most recent change of -$103.45 million (-17.78%) on December 31, 2023. During the last 3 years, it has fallen by -$241.77 million (-33.57%). RVNC annual total assets is now -33.57% below its all-time high of $720.22 million, reached on December 31, 2020.RVNC Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVNC Quarterly Total Assets
$461.56 M
-$33.23 M-6.72%
30 September 2024
Summary:
As of January 20, 2025, RVNC quarterly total assets is $461.56 million, with the most recent change of -$33.23 million (-6.72%) on September 30, 2024. Over the past year, it has dropped by -$70.92 million (-13.32%). RVNC quarterly total assets is now -35.91% below its all-time high of $720.22 million, reached on December 31, 2020.RVNC Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RVNC Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.8% | -13.3% |
| 3 y3 years | -33.6% | -20.7% |
| 5 y5 years | +111.4% | +73.6% |
RVNC Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -17.8% | at low | -35.1% | at low |
| 5 y | 5-year | -33.6% | +40.6% | -35.9% | +35.6% |
| alltime | all time | -33.6% | +3464.4% | -35.9% | +3338.6% |
Revance Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $461.56 M(-6.7%) |
| June 2024 | - | $494.80 M(-2.6%) |
| Mar 2024 | - | $508.12 M(+6.2%) |
| Dec 2023 | $478.45 M(-17.8%) | $478.45 M(-10.1%) |
| Sept 2023 | - | $532.49 M(-10.9%) |
| June 2023 | - | $597.53 M(+9.1%) |
| Mar 2023 | - | $547.80 M(-5.9%) |
| Dec 2022 | $581.90 M(+9.6%) | $581.90 M(-18.2%) |
| Sept 2022 | - | $711.59 M(+26.6%) |
| June 2022 | - | $561.88 M(-12.1%) |
| Mar 2022 | - | $639.55 M(+20.4%) |
| Dec 2021 | $531.16 M(-26.2%) | $531.16 M(-8.7%) |
| Sept 2021 | - | $581.83 M(-9.2%) |
| June 2021 | - | $640.88 M(-5.2%) |
| Mar 2021 | - | $675.95 M(-6.1%) |
| Dec 2020 | $720.22 M(+111.7%) | $720.22 M(+1.1%) |
| Sept 2020 | - | $712.15 M(+23.6%) |
| June 2020 | - | $576.18 M(-2.8%) |
| Mar 2020 | - | $592.93 M(+74.2%) |
| Dec 2019 | $340.29 M(+50.3%) | $340.29 M(+28.0%) |
| Sept 2019 | - | $265.81 M(-10.2%) |
| June 2019 | - | $295.89 M(-8.8%) |
| Mar 2019 | - | $324.48 M(+43.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $226.35 M(-23.5%) | $226.35 M(-2.9%) |
| Sept 2018 | - | $233.05 M(-10.1%) |
| June 2018 | - | $259.12 M(-9.0%) |
| Mar 2018 | - | $284.78 M(-3.7%) |
| Dec 2017 | $295.70 M(+44.7%) | $295.70 M(+74.8%) |
| Sept 2017 | - | $169.18 M(-9.6%) |
| June 2017 | - | $187.08 M(-10.7%) |
| Mar 2017 | - | $209.45 M(+2.5%) |
| Dec 2016 | $204.36 M(-25.9%) | $204.36 M(-9.9%) |
| Sept 2016 | - | $226.86 M(-4.3%) |
| June 2016 | - | $237.01 M(-8.5%) |
| Mar 2016 | - | $259.00 M(-6.1%) |
| Dec 2015 | $275.82 M(+43.3%) | $275.82 M(+66.6%) |
| Sept 2015 | - | $165.51 M(-3.3%) |
| June 2015 | - | $171.22 M(-2.6%) |
| Mar 2015 | - | $175.72 M(-8.7%) |
| Dec 2014 | $192.47 M(+749.9%) | $192.47 M(-7.9%) |
| Sept 2014 | - | $208.92 M(-6.4%) |
| June 2014 | - | $223.32 M(+108.9%) |
| Mar 2014 | - | $106.91 M(+372.1%) |
| Dec 2013 | $22.64 M(+68.7%) | $22.64 M(+19.7%) |
| Sept 2013 | - | $18.92 M(+41.0%) |
| Dec 2012 | $13.42 M(-66.4%) | $13.42 M |
| Dec 2011 | $39.93 M | - |
FAQ
- What is Revance Therapeutics annual total assets?
- What is the all time high annual total assets for Revance Therapeutics?
- What is Revance Therapeutics annual total assets year-on-year change?
- What is Revance Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Revance Therapeutics?
- What is Revance Therapeutics quarterly total assets year-on-year change?
What is Revance Therapeutics annual total assets?
The current annual total assets of RVNC is $478.45 M
What is the all time high annual total assets for Revance Therapeutics?
Revance Therapeutics all-time high annual total assets is $720.22 M
What is Revance Therapeutics annual total assets year-on-year change?
Over the past year, RVNC annual total assets has changed by -$103.45 M (-17.78%)
What is Revance Therapeutics quarterly total assets?
The current quarterly total assets of RVNC is $461.56 M
What is the all time high quarterly total assets for Revance Therapeutics?
Revance Therapeutics all-time high quarterly total assets is $720.22 M
What is Revance Therapeutics quarterly total assets year-on-year change?
Over the past year, RVNC quarterly total assets has changed by -$70.92 M (-13.32%)